Carl-Henrik Heldin
Carl-Henrik Heldin (born 9 August 1952) is Chairman of the Board for the Nobel Foundation, and a molecular biologist and medical researcher. He has been director of the Uppsala branch of Ludwig Cancer Research since 1986 and professor in molecular cell biology at the medical faculty of Uppsala University since 1992. He is vice-president of the European Research Council since 2011 and was appointed chairman of the Nobel Foundation in 2013.His research has focused on the mechanisms of signal transduction by growth regulatory factors like platelet-derived growth factor (PDGF) and transforming growth factor (TGF). He was senior editor of Cancer Research from 2003 to 2009. Provided by Wikipedia
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18by Agnieszka Kłosowska-Wardega, Yoko Hasumi, Mikhail Burmakin, Aive Ahgren, Linda Stuhr, Ingrid Moen, Rolf K Reed, Kristofer Rubin, Carina Hellberg, Carl-Henrik HeldinGet full text
Published 2009-12-01
Article -
19by Masato Morikawa, Daizo Koinuma, Anna Mizutani, Natsumi Kawasaki, Katarina Holmborn, Anders Sundqvist, Shuichi Tsutsumi, Tetsuro Watabe, Hiroyuki Aburatani, Carl-Henrik Heldin, Kohei MiyazonoGet full text
Published 2016-01-01
Article -
20by Ryo Tanabe, Kohei Miyazono, Tomoki Todo, Nobuhito Saito, Caname Iwata, Akiyoshi Komuro, Satoshi Sakai, Erna Raja, Daizo Koinuma, Masato Morikawa, Bengt Westermark, Carl‐Henrik HeldinGet full text
Published 2022-01-01
Article